<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864708</url>
  </required_header>
  <id_info>
    <org_study_id>B3252-R</org_study_id>
    <secondary_id>B3513R</secondary_id>
    <nct_id>NCT00864708</nct_id>
  </id_info>
  <brief_title>Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008</brief_title>
  <official_title>Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Alfred E. Mann Foundation for Scientific Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate new Technology for recovery of ankle walking
      function after stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Purpose: Conventional rehabilitation does not restore normal, upper limb
      function or normal gait to many stroke survivors. Functional neuromuscular stimulation (FNS)
      has shown promise for functional enhancement of both upper and lower limb motor control
      following stroke. Gains included muscle activation latencies, strength, coordination, upper
      limb functional tasks, gait kinematics, walking endurance, and quality of life. The purpose
      of the proposed work is to test the radio frequency-controlled (RF) Microstimulator (RFM)
      Gait System regarding system performance and subject response to treatment.

      Methods: This is a feasibility study in which up to four subjects will receive the (RFM) Gait
      System. Up to ten RFMs will be placed for a given subject. An RFM ankle muscle system will be
      used to train ankle gait components. A separate RFM system will be used to train knee gait
      components. Subjects will be treated for 6 months, four sessions/wk. Primary outcome measures
      for the RFM Gait System will be: kinematic swing phase gait components and walking endurance.
      Secondary outcome measures will include: strength, coordination, spasticity, function, and
      quality of life. Data collections will occur at months 1, 3 and 6, and for follow-up times up
      to a year after the end of treatment. The results of the RFM ankle system have the potential
      to provide a new technology for ankle muscle gait components.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The enrollment period/study duration had exceeded The Alfred Mann Foundation's timeline.
  </why_stopped>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Walking Endurance (6MWT)</measure>
    <time_frame>Day 1 and at 3 months, following treatment</time_frame>
    <description>The Six Minute Walk Test (6MWT) is a measure of the distance measured in feet ambulated by the participant during six minutes. A further distance walked in 6 minutes indicates improvement on the measure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kinematic Gait Measures</measure>
    <time_frame>Day 1 and at 3 months, following treatment</time_frame>
    <description>assessment of the lower limb kinematics during ambulation at chosen speed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Lower Extremity Score</measure>
    <time_frame>Day 1 and at 3 months, following treatment</time_frame>
    <description>Fugl-Meyer Lower Extremity Score (FMLE) is an itemized measure of lower extremity coordination following stroke. Scores for the FMLE range from 0 (most impaired) to 34 (normal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ashworth Scale</measure>
    <time_frame>Day 1 and at 3 months, following treatment</time_frame>
    <description>The Ashworth Scale is a measure of muscle spasticity; muscle groups are graded from 0 (no spasticity) to 4 (greatest spasticity/contracture). The lower limb muscle groups are summed for a total lower limb Ashworth score. A lower score indicates better performance. (range is 0-40)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Impact Scale (SIS)</measure>
    <time_frame>Day 1 and at 3 months, following treatment</time_frame>
    <description>The SIS is a measure of Quality of Life/Life Role Participation following stroke. Each item in a domain is scored between 0 and 5. A higher score indicates better performance (range 0-295).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manual Muscle Testing (MMT)</measure>
    <time_frame>Day 1 and at 3 months, following treatment</time_frame>
    <description>This is a measure of strength of the various muscle groups of the lower limb. Each is graded on a 0 to 5 scale; the final score is the summed total of the lower limb muscle groups tested. (score range of summed muscles is 0-50, with 50 being the maximum highest score)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>radio frequency-controlled (RF) Microstimulator (RFM) Gait System</intervention_name>
    <description>Fully Implanted FES system to assist patient with gait component practice</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sufficient endurance to participate in rehabilitation sessions.

          -  Medically Stable

          -  Age &gt;21 years.

          -  Inability to perform normal ankle coordinated gait components.

          -  Participants should be able to walk and keep balance without physical assistance from
             another person

        Exclusion Criteria:

          -  Acute or progressive cardiac, renal, respiratory, neurological disorders or
             malignancy.

          -  Lower motor neuron damage or radiculopathy

          -  Allergy or contraindication to anesthesia, Versed, (or comparable substitute.

          -  Active implantable device (e.g. pacemaker, implantable cardiac defibrillator,
             neurostimulator, or drug infusion device.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janis Daly, PhD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Medical Center, Cleveland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Medical Center, Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2009</study_first_posted>
  <results_first_submitted>November 25, 2013</results_first_submitted>
  <results_first_submitted_qc>May 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 26, 2014</results_first_posted>
  <last_update_submitted>May 7, 2014</last_update_submitted>
  <last_update_submitted_qc>May 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Functional Electrical Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Dec 2008 – October 2009, recruitment by flier and by word of mouth</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1</title>
          <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This was a feasibility study to test an RFM Gait System for re-training gait coordination. Number of participants was limited to sponsor timeline.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System )</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Walking Endurance (6MWT)</title>
        <description>The Six Minute Walk Test (6MWT) is a measure of the distance measured in feet ambulated by the participant during six minutes. A further distance walked in 6 minutes indicates improvement on the measure.</description>
        <time_frame>Day 1 and at 3 months, following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>gait training with radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
          </group>
        </group_list>
        <measure>
          <title>Walking Endurance (6MWT)</title>
          <description>The Six Minute Walk Test (6MWT) is a measure of the distance measured in feet ambulated by the participant during six minutes. A further distance walked in 6 minutes indicates improvement on the measure.</description>
          <units>feet</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1-6MWT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="843"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 3 months of treatment- 6MWT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="771"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fugl-Meyer Lower Extremity Score</title>
        <description>Fugl-Meyer Lower Extremity Score (FMLE) is an itemized measure of lower extremity coordination following stroke. Scores for the FMLE range from 0 (most impaired) to 34 (normal).</description>
        <time_frame>Day 1 and at 3 months, following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System )</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl-Meyer Lower Extremity Score</title>
          <description>Fugl-Meyer Lower Extremity Score (FMLE) is an itemized measure of lower extremity coordination following stroke. Scores for the FMLE range from 0 (most impaired) to 34 (normal).</description>
          <units>units on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1- Fugl Meyer Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 3 months of treatment- Fugl Meyer Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ashworth Scale</title>
        <description>The Ashworth Scale is a measure of muscle spasticity; muscle groups are graded from 0 (no spasticity) to 4 (greatest spasticity/contracture). The lower limb muscle groups are summed for a total lower limb Ashworth score. A lower score indicates better performance. (range is 0-40)</description>
        <time_frame>Day 1 and at 3 months, following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
          </group>
        </group_list>
        <measure>
          <title>Ashworth Scale</title>
          <description>The Ashworth Scale is a measure of muscle spasticity; muscle groups are graded from 0 (no spasticity) to 4 (greatest spasticity/contracture). The lower limb muscle groups are summed for a total lower limb Ashworth score. A lower score indicates better performance. (range is 0-40)</description>
          <units>units on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1-Ashworth Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 3 months of treatment- Ashworth Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stroke Impact Scale (SIS)</title>
        <description>The SIS is a measure of Quality of Life/Life Role Participation following stroke. Each item in a domain is scored between 0 and 5. A higher score indicates better performance (range 0-295).</description>
        <time_frame>Day 1 and at 3 months, following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
          </group>
        </group_list>
        <measure>
          <title>Stroke Impact Scale (SIS)</title>
          <description>The SIS is a measure of Quality of Life/Life Role Participation following stroke. Each item in a domain is scored between 0 and 5. A higher score indicates better performance (range 0-295).</description>
          <units>units on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1-SIS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="261"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 3 months of treatment- SIS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Manual Muscle Testing (MMT)</title>
        <description>This is a measure of strength of the various muscle groups of the lower limb. Each is graded on a 0 to 5 scale; the final score is the summed total of the lower limb muscle groups tested. (score range of summed muscles is 0-50, with 50 being the maximum highest score)</description>
        <time_frame>Day 1 and at 3 months, following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
          </group>
        </group_list>
        <measure>
          <title>Manual Muscle Testing (MMT)</title>
          <description>This is a measure of strength of the various muscle groups of the lower limb. Each is graded on a 0 to 5 scale; the final score is the summed total of the lower limb muscle groups tested. (score range of summed muscles is 0-50, with 50 being the maximum highest score)</description>
          <units>units on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1-MMT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 3 months of treatment- MMT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Kinematic Gait Measures</title>
        <description>assessment of the lower limb kinematics during ambulation at chosen speed.</description>
        <time_frame>Day 1 and at 3 months, following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System</description>
          </group>
        </group_list>
        <measure>
          <title>Kinematic Gait Measures</title>
          <description>assessment of the lower limb kinematics during ambulation at chosen speed.</description>
          <units>percentage of change Day 1 to 3 months</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>Gait training using radio frequency-controlled (RF) Microstimulator (RFM) Gait System )</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>delivery of unactivated stimuli (within comfort)</sub_title>
                <description>RFM system delivered unactivated stimuli (always reported within comfort) to subject unpredictably at times when system was powered up. AMF submitted device re-test data and reports to FDA which then re-approved continued use of the RFM system.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Principal Investigators are employed by the Department of Veterans Affairs (DVA) which funded the study; the Alfred P. Mann Foundation (AMF) provided the technology that was tested.
There was an agreement between the Principal Investigators of the DVA and the AMF that the AMF would be provided a period of time to review any manuscript for publication and provide input. There was no restriction regarding PI’s rights to discuss or publish the results.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study sponsor, Alfred Mann foundation (AMF) stopped study because “enrollment period/study duration has exceeded the AMF’s timeline”.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence</name_or_title>
      <organization>NF/SG VA Medical Center, Gainesville Florida</organization>
      <phone>(352) 376-1611 ext 5223</phone>
      <email>janis.daly@neurology.ufl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

